Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Board Changes

8 Apr 2026 07:00

RNS Number : 5405Z
Renishaw PLC
08 April 2026
 

Board Changes

 

Renishaw plc ("Company"), a leading provider of manufacturing technologies, analytical instruments and medical devices, announces the following changes to its Board of Directors ("Board").

 

 

Appointment of Chief Financial Officer

 

The Company is pleased to announce that following a comprehensive search process the Board has appointed John Shipsey as Chief Financial Officer ("CFO") and Executive Director with effect from 13 April 2026. 

 

John comes with significant Board and Executive Leadership experience, having undertaken the role of CFO in various companies in the listed and private setting, including 12 years at Dyson Limited, 5 years at Smiths Group plc and 2 years at Featurespace Limited. John also held finance and strategy roles at Diageo plc earlier in his career and served as a Non-executive Director of Dechra Pharmaceuticals PLC.

 

Sir David Grant, Interim Chair, commented "I would like to warmly welcome John to Renishaw and its Board. John brings a deep understanding of the industrials sector and its associated performance drivers. He has a strong track record of leading high-performing finance functions, and we look forward to him strengthening both the Board and Executive Leadership team."

 

 

Appointment of Chair

 

The Company also announces that the Board has decided to appoint Sir David Grant as its permanent Chair with immediate effect for a period of up to two years. The Board considers that Sir David has consistently demonstrated the competencies and leadership required of the Chair and his permanent appointment is in the best interests of the Company and its shareholders at this time. Sir David will retain his role as Chair of the Nomination Committee.

 

The search process for the Company's next Chair will continue with the aim of making an appointment by 2028. The Company is also continuing its search for an additional Independent Non-executive Director.

 

 

Appointment of Senior Independent Director

 

Following the appointment of Chair, the Company is also pleased to announce that Juliette Stacey has been appointed to the role of Senior Independent Director with immediate effect. Juliette was originally appointed as an Independent Non-executive Director of the Company on 1 January 2022 and has been Chair of the Audit Committee and served as a member of the Nomination and Remuneration Committees since her appointment.

 

There is no further information to be disclosed for the purposes of UK Listing Rule 6.4.8R.

 

Kasim Hussain

Group General Counsel & Company Secretary

8 April 2026

 

 

 

Renishaw plc

Registered office:

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number:

01106260, England and Wales

Telephone:

+44 (0)1453 524524

Website:

www.renishaw.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKDLFBQZLEBBD
Date   Source Headline
15th May 20097:00 amRNSInterim Management Statement
14th May 20092:11 pmRNSDirectorate Change
30th Mar 20092:08 pmRNSHolding(s) in Company
11th Mar 20098:00 amRNSTrading Statement
9th Feb 20092:29 pmRNSPatent litigation settlement
28th Jan 20097:30 amRNSHalf Yearly Report
23rd Jan 20093:32 pmRNSTrading statement & Interim results preview
24th Nov 20085:48 pmRNSAcquisition
30th Oct 20089:50 amRNSDirector/PDMR Shareholding
14th Oct 20084:43 pmRNSSecond Price Monitoring Extn
14th Oct 20084:38 pmRNSPrice Monitoring Extension
10th Oct 20081:11 pmRNSResult of AGM
10th Oct 20087:30 amRNSInterim Management Statement
4th Sep 200810:18 amRNSAnnual Information Update
18th Aug 20088:47 amRNSAnnual Report and Accounts
23rd Jul 20087:30 amRNSFinal Results
20th Jun 20088:10 amRNSDirectorate Change
19th Jun 20088:38 amRNSPatent legal proceeedings
8th May 20084:20 pmRNSStatement -Voting arrangement
8th May 20087:30 amRNSInterim Management Statement
6th May 20088:59 amRNSHolding(s) in Company
3rd Apr 20083:06 pmRNSHolding(s) in Company
3rd Apr 20082:28 pmRNSHolding(s) in Company
3rd Apr 20082:19 pmRNSDirector/PDMR Shareholding
25th Mar 20082:20 pmRNSHolding(s) in Company
21st Feb 20088:18 amRNSHolding(s) in Company
28th Jan 20082:10 pmRNSHolding(s) in Company
23rd Jan 20087:30 amRNSInterim Results
12th Oct 20072:41 pmRNSResult of AGM
12th Oct 200710:44 amRNSHolding(s) in Company
12th Oct 200710:43 amRNSHolding(s) in Company
12th Oct 20077:00 amRNSInterim Management Statement
20th Sep 20071:46 pmRNSNotice of EGM
7th Sep 200710:05 amRNSAnnual Information Update
17th Aug 20073:50 pmRNSAnnual Report and Accounts
25th Jul 20073:22 pmRNSHolding(s) in Company
25th Jul 20077:30 amRNSFinal Results
9th Jul 20074:30 pmRNSAcquisition
9th Jul 20071:53 pmRNSHolding(s) in Company
13th Jun 200711:26 amRNSHolding(s) in Company
11th Jun 20072:32 pmRNSTrading Statement
4th Jun 200711:42 amRNSRelated Party Transaction
24th Apr 200711:16 amRNSHolding(s) in Company
23rd Apr 200711:46 amRNSIssue of Equity
30th Mar 20078:17 amRNSAcquisition
27th Mar 20072:10 pmRNSHolding(s) in Company
20th Mar 20071:39 pmRNSHolding(s) in Company
9th Mar 20078:49 amRNSHolding(s) in Company
9th Mar 20078:46 amRNSHolding(s) in Company
26th Jan 20072:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.